Company Data

Cyclo Therapeutics Inc.

Ticker
CYTH
Current Price
$0.9098 -4.03%
Market Cap
$26.2M
Price Target
Refer to Report
Volume
87.1K
52wk Range
$0.55 - $1.92
Advanced Market Data

Overview

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy